Search
BioLife Solutions Inc
BLFSAdd to Watchlist
24.910USD
-1.130-4.34%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
1.19BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of BioLife Solutions Inc is 8.40, ranking 37 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 32.00, with a high of 34.00 and a low of 30.00.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
32.300
Target Price
+24.04%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
BioLife Solutions Inc
BLFS
10
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is BioLife Solutions Inc's expected revenue for the next quarter?
BioLife Solutions Inc's expected revenue is 27.57M.
What is BioLife Solutions Inc's price target?
Analysts forecast that BioLife Solutions Inc's price target is USD 32.00, with the highest forecast at USD 34.00 and the lowest forecast at USD 30.00.
How have BioLife Solutions IncBLFS's recent earnings per share performed?
The market expectation was USD 0.02, while BioLife Solutions IncBLFS's earnings per share (EPS) for the previous quarter was USD 0.23. EPS for the next quarter is expected at USD 0.03.
What is the analyst rating for BioLife Solutions Inc?
Based on the ratings of BioLife Solutions Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
